Introduction: The DNA of a Biotech BoomThe global plasmid DNA manufacturing market is entering a transformative era, driven ...

The Global Plasmid DNA Manufacturing Market is poised for significant growth, with a valuation of USD 2.13 Billion in 2024, and is projected to reach USD 10.67 Billion by 2033. The market is expected ...

A new study from the Faculty of Medicine at the Hebrew University of Jerusalem sheds light on how bacterial motion influences ...

Antibiotic resistance is a serious threat to public health. When antibiotics don't work, we risk not being able to treat many types of infections and people who would previously have been cured, can ...

However, the precise mechanisms through which saccharin can impact bacteria have remained elusive. In this work, we demonstrate that saccharin inhibits cell division, leading to cell filamentation ...

This new service delivers clinical-grade plasmid DNA production from cell bank to batch release in three months. This can help accelerate the development of gene and cell therapies. Located to serve ...

Restriction enzymes cut DNA creating complementary ‘sticky ends’ that join by base pairing. A different enzyme is used to join the insulin gene and the bacterial plasmid. The bacterial plasmid ...

Hopewell-based team delivers on ProBio's promise of speed, quality, and reliability—offering a transparent, fixed-cost model and ≥85% supercoiled plasmid DNA in record time for clinical programs.

Weiner, Ph.D., have described a next-generation vaccination technology that combines plasmid DNA with a lipid nanoparticle (LNP) delivery system. The research was conducted in collaboration with ...